NHI
Income statement / Annual
Last year (2024), National Health Investors, Inc.'s total revenue was $257.05 M,
a decrease of 19.63% from the previous year.
In 2024, National Health Investors, Inc.'s net income was $137.87 M.
See National Health Investors, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$257.05 M |
$319.84 M |
$278.19 M |
$298.72 M |
$332.81 M |
$318.08 M |
$294.61 M |
$278.66 M |
$248.50 M |
$228.99 M |
| Cost of Revenue |
$0.00
|
$11.51 M
|
$9.79 M
|
$11.64 M
|
$9.65 M
|
$5.80 M
|
$1.17 M
|
$960,000.00
|
$1.01 M
|
$985,000.00
|
| Gross Profit |
$257.05 M
|
$308.32 M
|
$268.41 M
|
$287.08 M
|
$323.16 M
|
$312.28 M
|
$293.45 M
|
$277.70 M
|
$247.49 M
|
$228.00 M
|
| Gross Profit Ratio |
1
|
0.96
|
0.96
|
0.96
|
0.97
|
0.98
|
1
|
1
|
1
|
1
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.23
|
$0.38
|
$0.57
|
$0.50
|
$0.52
|
$0.58
|
$0.65
|
$0.00
|
| General & Administrative Expenses |
$20.74 M
|
$19.72 M
|
$25.32 M
|
$19.34 M
|
$14.56 M
|
$13.91 M
|
$12.86 M
|
$12.71 M
|
$10.20 M
|
$10.98 M
|
| Selling & Marketing Expenses |
$0.00
|
$100,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$20.74 M
|
$19.82 M
|
$25.32 M
|
$19.34 M
|
$14.56 M
|
$13.91 M
|
$12.86 M
|
$12.71 M
|
$10.20 M
|
$10.98 M
|
| Other Expenses |
$21.52 M
|
$109.71 M
|
$99.92 M
|
$134.35 M
|
$84.68 M
|
$78.37 M
|
$71.35 M
|
$67.17 M
|
$1.66 M
|
$53.16 M
|
| Operating Expenses |
$42.25 M
|
$129.53 M
|
$125.24 M
|
$153.69 M
|
$99.23 M
|
$92.27 M
|
$85.37 M
|
$80.84 M
|
$70.77 M
|
$65.13 M
|
| Cost And Expenses |
$42.25 M
|
$143.36 M
|
$135.03 M
|
$165.33 M
|
$108.88 M
|
$98.07 M
|
$85.37 M
|
$80.84 M
|
$70.77 M
|
$65.13 M
|
| Interest Income |
-$3.78 M
|
-$2.65 M
|
$44.92 M
|
$50.81 M
|
$52.88 M
|
$56.30 M
|
$0.00
|
$0.00
|
$18,000.00
|
$0.00
|
| Interest Expense |
$56.12 M
|
$55.51 M
|
$44.92 M
|
$50.81 M
|
$52.88 M
|
$56.30 M
|
$49.06 M
|
$0.00
|
$43.11 M
|
$0.00
|
| Depreciation & Amortization |
$71.44 M
|
$69.97 M
|
$140.03 M
|
$165.45 M
|
$106.65 M
|
$99.16 M
|
$89.79 M
|
$79.96 M
|
$86.12 M
|
$53.16 M
|
| EBITDA |
$264.16 M |
$259.94 M |
$151.99 M |
$212.99 M |
$303.95 M |
$296.83 M |
$280.59 M |
$264.99 M |
$236.08 M |
$179.36 M |
| EBITDA Ratio |
1.03
|
0.81
|
0.55
|
0.71
|
0.91
|
0.93
|
0.95
|
0.95
|
0.95
|
0.94
|
| Operating Income Ratio |
0.84
|
0.56
|
0.29
|
0.44
|
0.66
|
0.69
|
0.71
|
0.71
|
0.72
|
0.72
|
| Total Other Income/Expenses Net |
-$76.93 M
|
-$44.41 M
|
-$80.22 M
|
-$15.04 M
|
-$33.54 M
|
-$59.56 M
|
-$49.94 M
|
-$38.45 M
|
-$74.13 M
|
-$66.10 M
|
| Income Before Tax |
$137.87 M
|
$134.38 M
|
$65.50 M
|
$111.97 M
|
$185.31 M
|
$160.45 M
|
$154.33 M
|
$159.37 M
|
$153.47 M
|
$149.61 M
|
| Income Before Tax Ratio |
0.54
|
0.42
|
0.24
|
0.37
|
0.56
|
0.5
|
0.52
|
0.57
|
0.62
|
0.65
|
| Income Tax Expense |
$0.00
|
$0.00
|
$42.44 M
|
$49.78 M
|
$49.94 M
|
$56.29 M
|
-$9.17 M
|
$46.32 M
|
$749,000.00
|
-$707,000.00
|
| Net Income |
$137.87 M
|
$135.65 M
|
$23.06 M
|
$62.19 M
|
$135.37 M
|
$104.16 M
|
$154.33 M
|
$159.37 M
|
$151.54 M
|
$148.86 M
|
| Net Income Ratio |
0.54
|
0.42
|
0.08
|
0.21
|
0.41
|
0.33
|
0.52
|
0.57
|
0.61
|
0.65
|
| EPS |
3.14 |
3.13 |
0.52 |
1.36 |
3.03 |
2.4 |
3.68 |
3.9 |
3.88 |
3.96 |
| EPS Diluted |
3.13 |
3.13 |
0.51 |
1.36 |
3.03 |
2.38 |
3.67 |
3.87 |
3.87 |
3.95 |
| Weighted Average Shares Out |
$43.84 M
|
$43.39 M
|
$44.77 M
|
$45.71 M
|
$44.70 M
|
$43.42 M
|
$41.94 M
|
$40.89 M
|
$39.01 M
|
$37.60 M
|
| Weighted Average Shares Out Diluted |
$44.10 M
|
$43.39 M
|
$44.79 M
|
$45.73 M
|
$44.70 M
|
$43.70 M
|
$42.09 M
|
$41.15 M
|
$39.16 M
|
$37.64 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
